Hot topics at ICH6
This article was originally published in SRA
Executive Summary
Manuel Zahn looks at the agenda for the 6th International Conference on Harmonisation in Osaka in November, 2003
You may also be interested in...
New Filings At The EMA
New medicines under evaluation at the European Medicines Agency.
Formycon And Bioeq Offer Ranibizumab Update
Formycon and partner Bioeq have offered further details on timing for the submission of their FYB201 proposed ranibizumab biosimilar version of Lucentis in Europe, the US and elsewhere.
Oxular Sets Out Eye Disease Plans Armed With $37m
The fresh cash injection will fund Phase II studies evaluating the UK firm's 12-month treatment for diabetic macular edema.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: